Dr. Gerard Reilly, M.D

NPI: 1326041740
Total Payments
$171,854
2024 Payments
$19,714
Companies
26
Transactions
202
Medicare Patients
259
Medicare Billing
$12,165

Payment Breakdown by Category

Research$90,948 (52.9%)
Consulting$65,347 (38.0%)
Food & Beverage$6,213 (3.6%)
Travel$4,812 (2.8%)
Other$4,510 (2.6%)
Education$23.68 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $90,948 59 52.9%
Consulting Fee $65,347 11 38.0%
Food and Beverage $6,213 111 3.6%
Travel and Lodging $4,812 17 2.8%
Honoraria $4,510 2 2.6%
Education $23.68 2 0.0%

Payments by Type

Research
$90,948
59 transactions
General
$80,906
143 transactions

Top Paying Companies

Company Total Records Latest Year
Bayer Healthcare Pharmaceuticals Inc. $92,449 74 $0 (2024)
Channel Medsystems, Inc. $47,010 8 $0 (2023)
Boston Scientific Corporation $11,173 17 $0 (2019)
Astellas Pharma US Inc $6,441 14 $0 (2024)
Meditrina $5,732 4 $0 (2024)
PFIZER INC. $4,803 5 $0 (2022)
Gynesonics, Inc. $1,072 9 $0 (2024)
Allen Medical Systems $800.00 1 $0 (2019)
ABBVIE INC. $625.45 24 $0 (2023)
Aspira Women's Health Inc $459.50 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $19,714 11 Bayer Healthcare Pharmaceuticals Inc. ($19,250)
2023 $35,673 30 Channel Medsystems, Inc. ($16,596)
2022 $41,674 24 Channel Medsystems, Inc. ($30,415)
2021 $609.98 10 Gynesonics, Inc. ($283.04)
2020 $19,858 48 Bayer HealthCare Pharmaceuticals Inc. ($19,650)
2019 $39,225 24 Bayer HealthCare Pharmaceuticals Inc. ($32,450)
2018 $14,481 43 Bayer HealthCare Pharmaceuticals Inc. ($8,725)
2017 $619.99 12 HOLOGIC INC ($225.85)

All Payment Transactions

202 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
11/18/2024 Gynesonics, Inc. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) Food and Beverage In-kind items and services $120.39 General
Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM
11/18/2024 Meditrina Food and Beverage Cash or cash equivalent $43.63 General
10/31/2024 Aspira Women's Health Inc OVA1 (Device) Food and Beverage In-kind items and services $14.03 General
Category: OB/GYN
09/19/2024 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $1,650.00 Research
Study: A multi-centre, multi-national clinical study to evaluate the safety and effectiveness of the Essure (Model ESS505) device to prevent pregnancy in women who are seeking permanent contraception • Category: Womens Health
08/27/2024 Hologic Sales and Service, LLC NOVASURE (Device) Food and Beverage In-kind items and services $48.77 General
Category: Surgical
08/16/2024 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $3,300.00 Research
Study: A multi-centre, multi-national clinical study to evaluate the safety and effectiveness of the Essure (Model ESS505) device to prevent pregnancy in women who are seeking permanent contraception • Category: Womens Health
07/17/2024 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $4,950.00 Research
Study: A multi-centre, multi-national clinical study to evaluate the safety and effectiveness of the Essure (Model ESS505) device to prevent pregnancy in women who are seeking permanent contraception • Category: Womens Health
07/03/2024 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $4,950.00 Research
Study: A multi-centre, multi-national clinical study to evaluate the safety and effectiveness of the Essure (Model ESS505) device to prevent pregnancy in women who are seeking permanent contraception • Category: Womens Health
04/23/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $124.59 General
Category: Biological
04/10/2024 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $4,400.00 Research
Study: A multi-centre, multi-national clinical study to evaluate the safety and effectiveness of the Essure (Model ESS505) device to prevent pregnancy in women who are seeking permanent contraception • Category: Womens Health
02/27/2024 Aspira Women's Health Inc OVA1 (Device) Food and Beverage In-kind items and services $112.35 General
Category: OB/GYN
11/30/2023 Hologic Sales and Service, LLC ACESSA PROVU SYSTEM (Device) Food and Beverage In-kind items and services $25.60 General
Category: Surgical
11/07/2023 Gynesonics, Inc. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) Food and Beverage In-kind items and services $137.21 General
Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM
09/19/2023 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $1,400.00 Research
Study: BAY1454033, pivotal • Category: Womens Health
08/18/2023 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $2,800.00 Research
Study: BAY1454033, pivotal • Category: Womens Health
07/31/2023 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $4,900.00 Research
Study: BAY1454033, pivotal • Category: Womens Health
07/27/2023 Bayer Healthcare Pharmaceuticals Inc. Mirena (Drug), Kyleena Food and Beverage In-kind items and services $17.52 General
Category: Womens Health
07/14/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $17.37 General
Category: Biological
07/11/2023 Gynesonics, Inc. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) Food and Beverage In-kind items and services $19.18 General
Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM
06/16/2023 Astellas Pharma US Inc Veozah (Drug) Consulting Fee Cash or cash equivalent $4,597.00 General
Category: Biological
06/16/2023 Bayer Healthcare Pharmaceuticals Inc. Essure (Device) Cash or cash equivalent $3,150.00 Research
Study: BAY1454033, pivotal • Category: Womens Health
06/16/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $300.98 General
Category: Biological
06/16/2023 Astellas Pharma US Inc Veozah (Drug) Travel and Lodging Cash or cash equivalent $129.98 General
Category: Biological
06/15/2023 Astellas Pharma US Inc Veozah (Drug) Travel and Lodging Cash or cash equivalent $517.80 General
Category: Biological
06/15/2023 Astellas Pharma US Inc Veozah (Drug) Travel and Lodging Cash or cash equivalent $269.48 General
Category: Biological

Research Studies & Clinical Trials

Study Name Company Amount Records
BAY1454033 pivotal Bayer HealthCare Pharmaceuticals Inc. $59,300 47
A multi-centre, multi-national clinical study to evaluate the safety and effectiveness of the Essure (Model ESS505) device to prevent pregnancy in women who are seeking permanent contraception Bayer Healthcare Pharmaceuticals Inc. $19,250 5
BAY1454033, pivotal Bayer Healthcare Pharmaceuticals Inc. $12,250 4
Bay1002670 Endometriosis Dose finding EU & US JP CN Bayer HealthCare Pharmaceuticals Inc. $148.04 3

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 68 68 $6,216 $2,880
2022 2 66 66 $5,835 $3,284
2021 2 69 73 $5,995 $3,657
2020 2 56 60 $4,675 $2,345
Total Patients
259
Total Services
267
Medicare Billing
$12,165
Procedure Codes
8

All Medicare Procedures & Services

8 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 35 35 $4,025 $1,656 41.1%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2023 33 33 $2,191 $1,224 55.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 28 28 $3,220 $1,813 56.3%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2022 38 38 $2,615 $1,471 56.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 29 33 $3,795 $2,111 55.6%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2021 40 40 $2,200 $1,546 70.3%
G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination Office 2020 40 40 $2,375 $1,579 66.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 16 20 $2,300 $766.38 33.3%

About Dr. Gerard Reilly, M.D

Dr. Gerard Reilly, M.D is a Obstetrics & Gynecology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326041740.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerard Reilly, M.D has received a total of $171,854 in payments from pharmaceutical and medical device companies, with $19,714 received in 2024. These payments were reported across 202 transactions from 26 companies. The most common payment nature is "" ($90,948).

As a Medicare-enrolled provider, Reilly has provided services to 259 Medicare beneficiaries, totaling 267 services with total Medicare billing of $12,165. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Cincinnati, OH
  • Active Since 05/31/2005
  • Last Updated 03/06/2025
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1326041740

Products in Payments

  • Non-Covered $59,448
  • Essure (Device) $31,607
  • Veozah (Drug) $6,362
  • Aveta (Device) $5,600
  • GENERAL UTERINE TISSUE REMOVAL (Device) $5,275
  • MYFEMBREE (Drug) $4,968
  • SYMPHION (Device) $4,408
  • SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $1,072
  • THERAPIES (Device) $942.04
  • Yellofins Stirrups with Lift Assist (Device) $800.00
  • OVA1 (Device) $459.50
  • GENERAL THERAPIES (Device) $447.17
  • ACESSA PROVU SYSTEM (Device) $221.87
  • Orilissa (Drug) $204.63
  • ORILISSA (Drug) $158.72
  • MYOSURE (Device) $124.17
  • FLOSEAL (Biological) $116.33
  • Lupron (Drug) $115.17
  • LO LOESTRIN FE (Drug) $112.72
  • GENERAL - UTERINE TISSUE REMOVAL (Device) $94.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Cincinnati